Injectable HIV Prevention Drug Faces Access Crisis Due to USAID Cuts
Lenacapavir injectable PrEP shows 99% effectiveness against HIV, but USAID funding cuts threaten access in developing nations, experts warn...
Injectable PrEP drug could slash HIV cases but funding cuts limit access
Lenacapavir injectable HIV prevention shows 99% effectiveness globally, yet USAID budget cuts threaten worldwide distribution and access to...
Injectable PrEP Drug Could Transform HIV Prevention Globally
New injectable HIV prevention medication shows 99% effectiveness, but USAID budget cuts threaten global access. Experts warn of prevention c...
Injectable HIV Prevention Drug Faces Access Crisis
Lenacapavir injectable PrEP could reduce global HIV cases dramatically, but USAID budget cuts threaten access in vulnerable nations.